Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-54296
Biochem Pharmacol 2018 Jan 01;147:153-169. doi: 10.1016/j.bcp.2017.11.006.
Show Gene links Show Anatomy links

Functional properties and mechanism of action of PPTQ, an allosteric agonist and low nanomolar positive allosteric modulator at GABA A receptors.

Madjroh N , Olander ER , Bundgaard C , Söderhielm PC , Jensen AA .


???displayArticle.abstract???
The former sedative-hypnotic and recreational drug methaqualone (Quaalude) is a moderately potent, non-selective positive allosteric modulator (PAM) at GABA A receptors (GABA A Rs) (Hammer et al., 2015). In the present study, we have identified a novel methaqualone analog, 2-phenyl-3-(p-tolyl)quinazolin-4(3H)-one (PPTQ), in a screening of 67 analogs at five αβ 2 γ 2S GABA A R subtypes and delineated its functional properties and mechanism of action at wild-type and mutant GABA A Rs expressed in Xenopus laevis oocytes by two-electrode voltage clamp electrophysiology. PPTQ was found to be an allosteric agonist and a PAM (ago-PAM) at human α 1 β 2 γ 2S and α 4 β 2 δ GABA A Rs, exhibiting intrinsic activity at micromolar concentrations and potentiating the GABA-evoked signaling through the receptors at concentrations down to the low-nanomolar range. Whereas PPTQ exclusively increased the potency of GABA at the α 1 β 2 γ 2S receptor, it increased both GABA potency and efficacy at α 4 β 2 δ and displayed modest potency-based preference for α 4 β 2 δ over α 1 β 2 γ 2S . In elaborate mutagenesis and competition experiments PPTQ was found to act through the same or an overlapping site as etomidate in the transmembrane β (+) /α (-) subunit interfaces, whereas it did not seem to target the other three transmembrane interfaces in the GABA A R. Finally, the PPTQ site was shown to be allosterically linked with sites targeted by neurosteroids and barbiturates but not with the high-affinity benzodiazepine site in the α 1 β 2 γ 2S receptor. In conclusion, the development of a highly potent, bioavailable GABA A R ago-PAM by subtle modifications to the methaqualone scaffold demonstrates that derivatization of this infamous drug from the past can lead to modulators with distinct functional characteristics at the receptors.

???displayArticle.pubmedLink??? 29155148
???displayArticle.link??? Biochem Pharmacol


Species referenced: Xenopus laevis
Genes referenced: pam